Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack T Stapleton

Showing results (121-130 of 147) with videos related to

Pageof 15
Sort By:
The Journal of Infectious Diseases|March 6, 2021
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity ResponsesSharon E Frey, Jack T Stapleton, Zuhair K Ballas, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Integrated analysis of protein sequence and structure redefines viral diversity and the taxonomy of the <i>Flaviviridae</i>Peter Simmonds, Anamarija Butković, Joe Grove, et al.
Nature Microbiology|November 1, 2025
Taxonomic expansion and reorganization of FlaviviridaePeter Simmonds, Anamarija Butković, Joe Grove, et al.
Archives of Virology|August 10, 2023
Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family FlaviviridaeThomas S Postler, Martin Beer, Bradley J Blitvich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Plos One|June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old SubjectsRichard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
Journal of Immunological Methods|June 1, 2024
Establishment of human post-vaccination SARS-CoV-2 standard reference seraJinhua Xiang, Louis Katz, Patricia L Winokur, et al.
The New England Journal of Medicine|January 6, 2012
Efficacy results of a trial of a herpes simplex vaccineRobert B Belshe, Peter A Leone, David I Bernstein, et al.
The Journal of Infectious Diseases|July 12, 2012
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older personsLisa A Jackson, Wilbur H Chen, Jack T Stapleton, et al.
Vaccine|July 27, 2007
Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infectionsChristina A Scherer, Charles L Magness, Kathryn V Steiger, et al.
Pageof 15

Showing results (121-130 of 147) with videos related to

Sort By:
Pageof 15
The Journal of Infectious Diseases|March 6, 2021
Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity ResponsesSharon E Frey, Jack T Stapleton, Zuhair K Ballas, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Integrated analysis of protein sequence and structure redefines viral diversity and the taxonomy of the <i>Flaviviridae</i>Peter Simmonds, Anamarija Butković, Joe Grove, et al.
Nature Microbiology|November 1, 2025
Taxonomic expansion and reorganization of FlaviviridaePeter Simmonds, Anamarija Butković, Joe Grove, et al.
Archives of Virology|August 10, 2023
Renaming of the genus Flavivirus to Orthoflavivirus and extension of binomial species names within the family FlaviviridaeThomas S Postler, Martin Beer, Bradley J Blitvich, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 1, 2019
Human Pegivirus Infection and Lymphoma Risk: A Systematic Review and Meta-analysisAngelo Fama, Melissa C Larson, Brian K Link, et al.
Plos One|June 22, 2016
A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old SubjectsRichard N Greenberg, Christine M Hay, Jack T Stapleton, et al.
Journal of Immunological Methods|June 1, 2024
Establishment of human post-vaccination SARS-CoV-2 standard reference seraJinhua Xiang, Louis Katz, Patricia L Winokur, et al.
The New England Journal of Medicine|January 6, 2012
Efficacy results of a trial of a herpes simplex vaccineRobert B Belshe, Peter A Leone, David I Bernstein, et al.
The Journal of Infectious Diseases|July 12, 2012
Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older personsLisa A Jackson, Wilbur H Chen, Jack T Stapleton, et al.
Vaccine|July 27, 2007
Distinct gene expression profiles in peripheral blood mononuclear cells from patients infected with vaccinia virus, yellow fever 17D virus, or upper respiratory infectionsChristina A Scherer, Charles L Magness, Kathryn V Steiger, et al.
Pageof 15